This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.

Contact Us

What can we help you find?

Top Searches

PROTAC

ADC

RNA

ADME

OLIGO

Evaluation of Time-Dependent Inhibition (TDI) of CYP3A4 by Peptide Therapeutics:A Comparison of Human Hepatocyte and Human Liver Microsome Assays

  • Posters

  • May 29,2026

Posters Overview

With the rapid expansion of peptide and peptidomimetic therapeutics, evaluating their Drug-Drug Interaction (DDI) potential has become an essential part of drug development. Cytochrome P450 3A4 (CYP3A4) inhibition is a primary driver of clinical DDIs. While traditional linear peptides are generally metabolized by proteases and pose low CYP-mediated DDI risks, modified and cyclic peptides may interactwith CYP enzymes. This study aims to evaluate the CYP3A4 (using Midazolam as a specific substrate) direct and time-dependent inhibition (TDI) potential of a diverse panel of peptide therapeutics.

Evaluation-of-Time-Dependent-Inhibition-(TDI)-of-CYP3A4-by-Peptide-TherapeuticsA-Comparison-of-Human-Hepatocyte-and-Human-Liver-Microsome-Assays.jpg

Complete the form to view and download this poster.

  • First name *
    * Please check the filled content
  • Last name *
    * Please check the filled content
  • Email address *
    * Please check the filled content
  • Phone number
  • Company *
    * Please enter a valid e-mail address
  • Department *
    * Please check the filled content
  • Country/District *
    * Please check the filled content
  • Position *
    * Please check the filled content
  • City *
    * Please check the filled content
  • Focus area (Service you are interested in)
  • I want to receive the latest news, insights, and communication from WuXi AppTec DMPK. I understand that I can unsubscribe at any time.

    I acknowledge and agree that WuXi AppTec DMPK may transfer my personal information across borders for the purpose of providing products and services through resources worldwide.

    By clicking submit below, you consent to WuXi AppTec DMPK collecting and processing the information you provide for our internal purposes, in accordance with our privacy policy.

    * Please agree to the Privacy Policy

Stay Connected

Keep up with the latest news and insights.

  • Email address*

    * Please check the filled content
  • First name*

    * Please check the filled content
  • Last name*

    * Please check the filled content
  • Company*

    * Please check the filled content

By clicking submit, you consent to WuXi AppTec DMPK collecting and processing the information you provide for our internal purposes, in accordance with our privacy policy.

* Please agree to the Privacy Policy

Thanks for signing up

Help us get to know you better! By customizing your email preferences, we can deliver curated content relevant to you.

Thanks for signing up

Help us get to know you better! By customizing your email preferences, we can deliver curated content relevant to you.